PEXITAZ 500


infusion 1 x 50ml
scheduling status
S0
registration number
51/26/0232
What PEXITAZ 500 is and what it is used for
PEXITAZ is indicated for the treatment of patients with malignant pleural mesothelioma in combination with cisplatin.
dosage
PEXITAZ is administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle.
how to take
PEXITAZ should only be administered under the supervision of a medical practitioner qualified in the use of anti-cancer chemotherapy.
What PEXITAZ 500 contains
Pemetrexed disodium heptahydrate.
other ingredients
Hydrochloric acid, mannitol, nitrogen pure, sodium hydroxide.
Therapeutic classification
L01BA.
© 2026 SAHPRA. ALL RIGHTS RESERVED